Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5280945
Max Phase: Preclinical
Molecular Formula: C18H19N5
Molecular Weight: 305.39
Associated Items:
ID: ALA5280945
Max Phase: Preclinical
Molecular Formula: C18H19N5
Molecular Weight: 305.39
Associated Items:
Canonical SMILES: CCCCn1cnc2c(Cc3cccc(C)c3)nc(C#N)nc21
Standard InChI: InChI=1S/C18H19N5/c1-3-4-8-23-12-20-17-15(21-16(11-19)22-18(17)23)10-14-7-5-6-13(2)9-14/h5-7,9,12H,3-4,8,10H2,1-2H3
Standard InChI Key: QOTNQMXDCXJKBX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 305.39 | Molecular Weight (Monoisotopic): 305.1640 | AlogP: 3.40 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.39 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.25 | CX LogD: 4.25 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.72 | Np Likeness Score: -1.19 |
1. Rocha DA, Silva EB, Fortes IS, Lopes MS, Ferreira RS, Andrade SF.. (2018) Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors., 157 [PMID:30282318] [10.1016/j.ejmech.2018.08.079] |
Source(1):